These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16918945)

  • 1. Corticosteroids and the cardiovascular response to stress: a pilot study of the 35% CO2 challenge in Addison's disease.
    Kaye JM; Lightman SL
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):282-6. PubMed ID: 16918945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The four-dimensional stress test: psychological, sympathetic-adrenal-medullary, parasympathetic and hypothalamic-pituitary-adrenal responses following inhalation of 35% CO2.
    Wetherell MA; Crown AL; Lightman SL; Miles JN; Kaye J; Vedhara K
    Psychoneuroendocrinology; 2006 Jul; 31(6):736-47. PubMed ID: 16621326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin regulation of the human stress response.
    Hood SD; Hince DA; Robinson H; Cirillo M; Christmas D; Kaye JM
    Psychoneuroendocrinology; 2006 Oct; 31(9):1087-97. PubMed ID: 16962720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam.
    Fries E; Hellhammer DH; Hellhammer J
    Psychoneuroendocrinology; 2006 Nov; 31(10):1278-88. PubMed ID: 17097811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers.
    Bailey JE; Argyropoulos SV; Kendrick AH; Nutt DJ
    Depress Anxiety; 2005; 21(1):18-25. PubMed ID: 15782425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-pituitary-adrenal axis function following a 35% CO2 inhalation in healthy volunteers.
    van Duinen MA; Schruers KR; Jaegers E; Maes M; Griez EJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):279-83. PubMed ID: 14751423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nicotine on 35% CO2-induced anxiety: A study in healthy volunteers.
    Cosci F; Abrams K; Schruers KR; Rickelt J; Griez EJ
    Nicotine Tob Res; 2006 Aug; 8(4):511-7. PubMed ID: 16920648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oedema in patients with Addison's disease on replacement therapy: glucocorticoid excess and mineralocorticoid deficiency?
    Flynn MD; Shore AC; Sandeman DE; Mawson D; Donohoe M; Tooke JE
    QJM; 1994 Jul; 87(7):437-41. PubMed ID: 7922296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M; Gryczyńska M; Sowińska A; Sowiński J
    Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trial.
    Nenke MA; Haylock CL; Rankin W; Inder WJ; Gagliardi L; Eldridge C; Rolan P; Torpy DJ
    Psychoneuroendocrinology; 2015 Jun; 56():157-67. PubMed ID: 25827960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures.
    Papadopoulos A; Rich A; Nutt DJ; Bailey JE
    J Psychopharmacol; 2010 May; 24(5):649-56. PubMed ID: 18832434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin, but not propranolol, attenuates the acute stress-induced increase in circulating levels of interleukin-6: a randomized, double-blind, placebo-controlled study.
    von Känel R; Kudielka BM; Metzenthin P; Helfricht S; Preckel D; Haeberli A; Stutz M; Fischer JE
    Brain Behav Immun; 2008 Feb; 22(2):150-7. PubMed ID: 17881186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in patients with Addison's disease: effects of different cortisol replacement modes.
    Riedel M; Wiese A; Schürmeyer TH; Brabant G
    Exp Clin Endocrinol; 1993; 101(2):106-11. PubMed ID: 8405139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses to the 35% CO challenge in postpartum women.
    Kaye J; Soothill P; Hunt M; Lightman S
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):582-8. PubMed ID: 15521960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
    Gagliardi L; Nenke MA; Thynne TR; von der Borch J; Rankin WA; Henley DE; Sorbello J; Inder WJ; Torpy DJ
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute carbon dioxide exposure in healthy adults: evaluation of a novel means of investigating the stress response.
    Kaye J; Buchanan F; Kendrick A; Johnson P; Lowry C; Bailey J; Nutt D; Lightman S
    J Neuroendocrinol; 2004 Mar; 16(3):256-64. PubMed ID: 15049856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
    Chittiprol S; Kumar AM; Satishchandra P; Taranath Shetty K; Bhimasena Rao RS; Subbakrishna DK; Philip M; Satish KS; Ravi Kumar H; Kumar M
    Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acute effect of a mineralocorticoid receptor agonist on corticotrope secretion in Addison's disease.
    Berardelli R; Karamouzis I; D'Angelo V; Fussotto B; Minetto MA; Ghigo E; Giordano R; Arvat E
    J Endocrinol Invest; 2016 May; 39(5):537-42. PubMed ID: 26450146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addison's disease in pregnancy: Case report, management, and review of the literature.
    Margulies SL; Corrigan K; Bathgate S; Macri C
    J Neonatal Perinatal Med; 2020; 13(2):275-278. PubMed ID: 31744021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual dysfunctions in men affected by autoimmune Addison's disease before and after short-term gluco- and mineralocorticoid replacement therapy.
    Granata A; Tirabassi G; Pugni V; Arnaldi G; Boscaro M; Carani C; Balercia G
    J Sex Med; 2013 Aug; 10(8):2036-43. PubMed ID: 22429298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.